Drug combinations with proteasome inhibitors in antitumor therapy.
about
Clinical use of proteasome inhibitors in the treatment of multiple myelomaInvestigation of Vietnamese plants for potential anticancer agents.Bortezomib Alone and in Combination With Salinosporamid A Induces Apoptosis and Promotes Pheochromocytoma Cell Death In Vitro and in Female Nude Mice.Positioning of proteasome inhibitors in therapy of solid malignancies.The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma.Bladder cancer detection using a peptide substrate of the 20S proteasome.Multifunctional Telodendrimer Nanocarriers Restore Synergy of Bortezomib and Doxorubicin in Ovarian Cancer Treatment.
P2860
Q28080999-8421FCFA-5311-4E71-8E73-10775A81A339Q34478640-7FAB4F99-2FBC-4981-B1E8-C99A9DEE22F8Q41932078-DB1EB511-9501-4FD9-902D-25D2BE692D56Q47353792-576E1FB4-BF47-44A8-854F-5EF78479EA20Q51746838-ECEF12FA-B804-4316-A3C3-ED22EE5115C1Q53037193-F51948E5-8FC9-4C2D-981E-31565958BF4AQ55265735-5325282C-6F4B-4AED-ACBC-2F5FEDA3263D
P2860
Drug combinations with proteasome inhibitors in antitumor therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Drug combinations with proteasome inhibitors in antitumor therapy.
@en
type
label
Drug combinations with proteasome inhibitors in antitumor therapy.
@en
prefLabel
Drug combinations with proteasome inhibitors in antitumor therapy.
@en
P50
P1476
Drug combinations with proteasome inhibitors in antitumor therapy.
@en
P304
P356
10.2174/1381612811319220015
P577
2013-01-01T00:00:00Z